RPH3A and neurohypophyseal diabetes insipidus: Based on a small series of patients, rabphilin-3A has been identified as a major autoantigen in LINH, which has led to the recommendation to use autoantibodies to rabphilin-3A as a biomarker for the diagnosis of LINH, and in the differential diagnosis in patients with AVP deficiency [19,20].